Tiehua Rong, M.D. Professor, the secretary of the Party  Committee of the Cancer  Center, Director of the Department of Thoracic Oncology, Chief Scientist on Esophagus Cancer.

Address:
     Department of Thoracic Oncology
     Cancer Center, Zhongshan University.
     651 Dongfeng East Road, 
     Guangzhou 510060,
      P. R. China.
      Tel: +86-20-87765368 ext. 5286
      Fax: +86-20-87754506

Background:
       Dr. Rong  received  his M.D. from Sun Yat-Sen University of Medical Sciences (SUMS) in 1970. From 1991 to 1992,  he took his advanced studies at the chest hospital of Berlin, Germany. He is a postgraduate supervisor in our Cancer Center, vice director of executive committee of Guangdong  branch, Chinese Medical Society. Dr. Rong is an accomplished expert on clinical  research of esophag us carcinoma and  has accumulated abundant clinical experiences on surgical and combined therapy for esophagus carcinoma, implementing  esophageal stapler, mediastinal lymph  nodes cleaning, bronchoplasty, and excision of mediastinal tumor.  In recent years,  he has performed total esophagectomy and esophagopharynostomy for upper or cervical esophageal carcinoma,  esophagectomy with lymphnodes  cleaning  in  cervical, thoracic  and  abdominal  region.  Another focus of  his research is the therapy of pulmonary carcinoma .He modified the traditional  mediastinal lymph nodes cleaning  procedures,  which  has been proved to improve radical effects with decreased complication occurrence. Additionally,  he also developed complex pulmonary lobectomy, mediastinal lymph nodes cleaning and partial left artriectomy in order to expand the indication and excision rate of the  pulmonary  carcinoma. There  are  six  ongoing  projects under the charge of  Dr. Rong  supported by various grants:  Study on prevention and  control of cancer  in Yuexiu Section in Guangzhou; modification of surgical method of  lymph node cleaning in patients  with left non-small cell  lung  carcinoma;  research on ombined  treatment for lung carcinoma;  optimized therapy  for esophageal carcinom of  advanced stage; study on enlarging the operative indications for lung cancer;  implementing LAK cell as a palliative therapy for post-operative lung cancer.

Recent publications: 
   1.Surgical treatment of postoperative anastomosis stenosis in esophageal and cardiac carcinoma.
                          Chinese J Cancer 1995; 14(4): 280-282.
   2.The clinical application of esophageal stapler.
                          Chinese J Cancer 1994; 13(1): 44-46.
   3.The clinical study of using the esophageal stapler.
                          Acad J SUMS 1996; 17(1): 67-69.
   4.Contributor of several monograph, including Oncologic Surgery.
       Chinese Gerontology and Clinical Thoracic Oncology.